David T. Doherty Sells 13,641 Shares of Surgery Partners, Inc. (NASDAQ:SGRY) Stock

Surgery Partners, Inc. (NASDAQ:SGRY - Get Free Report) CFO David T. Doherty sold 13,641 shares of Surgery Partners stock in a transaction dated Friday, February 7th. The stock was sold at an average price of $25.61, for a total value of $349,346.01. Following the sale, the chief financial officer now owns 108,862 shares in the company, valued at $2,787,955.82. This trade represents a 11.14 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Surgery Partners Price Performance

Shares of Surgery Partners stock traded up $0.44 on Thursday, hitting $25.79. The company had a trading volume of 685,428 shares, compared to its average volume of 1,541,284. The business has a 50-day simple moving average of $21.99 and a 200-day simple moving average of $26.84. The company has a debt-to-equity ratio of 0.99, a current ratio of 1.80 and a quick ratio of 1.66. The company has a market cap of $3.28 billion, a PE ratio of -53.73, a PEG ratio of 17.77 and a beta of 2.60. Surgery Partners, Inc. has a 52 week low of $19.50 and a 52 week high of $35.29.

Surgery Partners (NASDAQ:SGRY - Get Free Report) last posted its quarterly earnings results on Tuesday, November 12th. The company reported $0.19 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.06). The business had revenue of $770.40 million during the quarter, compared to analyst estimates of $768.99 million. Surgery Partners had a positive return on equity of 2.85% and a negative net margin of 2.03%. The company's quarterly revenue was up 14.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.15 EPS. Research analysts expect that Surgery Partners, Inc. will post 0.71 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Macquarie reaffirmed an "outperform" rating and issued a $34.00 price objective on shares of Surgery Partners in a report on Tuesday, November 19th. Bank of America initiated coverage on Surgery Partners in a report on Monday, December 16th. They issued a "buy" rating and a $30.00 price target for the company. JPMorgan Chase & Co. dropped their price objective on Surgery Partners from $38.00 to $28.00 and set a "neutral" rating for the company in a report on Tuesday, December 3rd. Finally, Royal Bank of Canada dropped their price objective on Surgery Partners from $49.00 to $35.00 and set an "outperform" rating for the company in a report on Wednesday, November 20th. One research analyst has rated the stock with a sell rating, three have given a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Surgery Partners has an average rating of "Moderate Buy" and a consensus target price of $36.56.

Hedge Funds Weigh In On Surgery Partners

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Handelsbanken Fonder AB boosted its stake in shares of Surgery Partners by 35.1% during the 3rd quarter. Handelsbanken Fonder AB now owns 18,100 shares of the company's stock valued at $584,000 after buying an additional 4,700 shares during the period. Creative Planning acquired a new position in Surgery Partners during the 3rd quarter worth $258,000. E. Ohman J or Asset Management AB increased its holdings in shares of Surgery Partners by 31.0% during the 3rd quarter. E. Ohman J or Asset Management AB now owns 886,088 shares of the company's stock worth $28,567,000 after purchasing an additional 209,888 shares during the period. Smith Group Asset Management LLC increased its holdings in shares of Surgery Partners by 48.6% during the 3rd quarter. Smith Group Asset Management LLC now owns 16,160 shares of the company's stock worth $521,000 after purchasing an additional 5,282 shares during the period. Finally, Harbor Capital Advisors Inc. increased its stake in Surgery Partners by 16.0% in the third quarter. Harbor Capital Advisors Inc. now owns 53,855 shares of the company's stock valued at $1,736,000 after acquiring an additional 7,441 shares during the period.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.